Gilead Sciences (GILD) Current Assets (2009 - 2026)

Gilead Sciences has reported Current Assets for 18 years, with the latest figure at $18.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 10.3% year-over-year to $18.6 billion; the trailing twelve-month figure through Mar 2026 stood at $18.6 billion (up 10.3% YoY), and the FY2025 full-year result was $18.3 billion, down 4.33% from the prior year.
• Current Assets for Q1 2026 stood at $18.6 billion, up from $18.3 billion in the prior quarter.
• The five-year high for Current Assets was $19.2 billion in Q4 2024, with the low at $12.3 billion in Q2 2024.
• Historically, Current Assets has averaged $15.3 billion across 5 years, with a median of $14.7 billion in 2025.
• Annual changes were most pronounced in 2024 — Current Assets fell 13.79% — and 2025, when it gained 20.94%.
• Gilead Sciences' Current Assets stood at $14.4 billion in 2022, then rose by 11.37% to $16.1 billion in 2023, then gained by 19.2% to $19.2 billion in 2024, then declined by 4.33% to $18.3 billion in 2025, then grew by 1.63% to $18.6 billion in 2026.
• The last three Current Assets figures came in at $18.6 billion (Q1 2026), $18.3 billion (Q4 2025), and $17.9 billion (Q3 2025), per Business Quant data.